Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$3.1400
0.0000 (0.0000%)
- Prev. close
- 3.1400
- Volume
- 0
- High
- 3.2100
- Capitalization
- 142.821M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€3.3500
+0.3560 (11.8904%)
- Prev. close
- 2.9940
- Volume
- 354,224
- High
- 3.3800
- Capitalization
- 152.342M
Covering research analysts
Barclays - Gena Wang
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter
Jefferies - Kelly Shi
JMP Securities - Silvan Tuerkcan
Jones Trading - Soumit Roy
Kempen - Ingrid Gafanhão
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
RW Baird - Jack Allen
Wells Fargo – Nick Abbott
William Blair – Raju Prasad
SMBC - David Dai
Cellectis contact information
Arthur Stril, Chief Business Officer
Ashley R. Robinson, LifeSci Advisors
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89